青年型非小细胞肺癌治疗研究进展  

Research Progress of Treatment for NSCLC in Young Patients

作　　者：周思成 沈诚[1] 车国卫[1,2] Sicheng ZHOU;Cheng SHEN;Guowei CHE(Department of Thoracic Surgery,West China Hospital,Sichuan University,Chengdu 610041,China;Lung Cancer Center,West China Hospital,Sichuan University,Chengdu 610041,China)

机构地区：[1]四川大学华西医院胸外科,成都610041 [2]四川大学华西医院肺癌中心,成都610041

出　　处：《中国肺癌杂志》2022年第12期888-894,共7页Chinese Journal of Lung Cancer

摘　　要：青年型非小细胞肺癌(non-small cell lung cancer,NSCLC)患者(≤45岁)尽管占比较低,但其有独特的临床病理特征,近年来患病率有上升的趋势。随着肺癌个体化治疗观念的提出,其研究也逐渐受到重视。另外,青年型NSCLC患者在治疗反应和预后等方面与老年肺癌患者有所不同,因此对青年型NSCLC进行研究极具临床意义。本文就青年型NSCLC患者的临床表现、治疗手段和预后等特点作一综述。Non-small cell lung cancer(NSCLC)young patients(≤45 years old),despite their low prevalence,have unique clinical and pathological features.Its morbidity has been on the rise in recent years.With the concept of individualized lung cancer treatment,related researches are gradually gaining attention.In addition,the treatment response and prognosis in NSCLC young patients are different from older patients,so the study of NSCLC young patients is of great clinical significance.This article reviews the clinical manifestations,treatment and prognosis of NSCLC young patients.

关 键 词：肺肿瘤 综合治疗 青年患者 临床特点 预后 

分 类 号：R734.2[医药卫生—肿瘤]